ABT vs GMGI · P/E 25, rev $44.33B vs rev $151.1M
Abbott Laboratories (ABT) versus Golden Matrix Group Inc (GMGI) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Golden Matrix Group Inc (GMGI) is a electronic gaming & multimedia company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GMGI revenue for 2024-12-31 was $151.1M. Net income was -$1.4M. Revenue was up 62.5% from 2023-12-31 to 2024-12-31. GMGI currently screens at market cap $8.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GMGI currently screens at market cap $8.1M.
Not investment advice. Open the ABT and GMGI stock pages for the full models.
Not investment advice.